Nitric oxide (NO) and somatostatin (SS) are two important mediators of the exocrine and endocrine pancreas, exerting opposite effects on this organ. There is strong evidence suggesting an interaction between pancreatic NO and SS. The aim of this study was to determine whether L-arginine (L-Arg), the substrate for NO synthase (NOS), and N g -nitro-L-arginine methyl ester (L-NAME), a NOS inhibitor, regulate pancreatic somatostatin-like immunoreactivity (SSLI) content and the SS mechanism of action in pancreatic acinar cell membranes. L-Arg (150 mg/kg, intraperitoneally (i.p.)), L-NAME (50 mg/kg, i.p.) or L-NAME plus L-Arg were injected twice daily at 8 h intervals for 8 days. L-Arg decreased pancreatic SSLI content as well as the number of SS receptors in pancreatic acinar cell membranes whereas L-NAME increased both parameters. The stable SS analogue SMS 201-995 induced a significantly lower inhibition of forskolin-stimulated adenylyl cyclase activity in pancreatic acinar cell membranes from L-Arg-treated rats whereas an increased inhibition was observed in pancreatic acinar membranes from L-NAME-treated rats. These results indicate that the NO system may contribute to the regulation of the pancreatic somatostatinergic system. ß
Introduction
Nitric oxide (NO) and somatostatin (SS) are two important mediators of the exocrine and endocrine pancreas. The gaseous compound NO has recently been discovered to be an important intra-and intercellular messenger in a number of organ systems [1] . It is synthesized from molecular O 2 and the guanidino group of L-arginine (L-Arg) by NO synthase (NOS) [1] . NO has been puri¢ed, characterized and cloned from brain, macrophages and endothelial cells [1^3] . It binds to iron in the heme group of soluble guanylate cyclase, stimulating the formation of guanosine 3P-5P-cyclic monophosphate (cGMP) [2] . Recent studies have suggested that NO may be an important neurotransmitter in the pancreas. NOS has been located in the pancreas, not only in ganglia or nerve terminals innervating acinar tissue and islets, but also in A and B cells [4^6] . In addition, puri¢ca-0167-4889 / 99 / $^see front matter ß 1999 Elsevier Science B.V. All rights reserved. PII: S 0 1 6 7 -4 8 8 9 ( 9 9 ) 0 0 0 3 2 -4
Abbreviations: BSA, bovine serum albumin; GTP, guanosine triphosphate; IBMX, 3-isobutyl-1-methylxanthine; 125 I-Tyr 11 -SS, 125 I-Tyr 11 -somatostatin; L-NAME, N g -nitro-L-arginine methyl ester; NO, nitric oxide; NOS, nitric oxide synthase; PMSF, phenylmethylsulfonyl£uoride ; SSLI, somatostatin-like immunoreactivity; SS, somatostatintion of NOS from isolated pancreatic acini demonstrates the presence of this enzyme in acinar cells and supports a direct role for NO as a regulator of pancreatic exocrine function at the level of the acinar cells [5, 7] . In this regard, L-Arg has been shown to induce an increase in amylase [5] and insulin release [8^10] in the rat pancreas. Inhibitors of the enzymatic conversion of L-Arg to NO inhibited insulin secretion induced by L-Arg in the presence of D-glucose [8] . Colocalization of neuronal NOS and SS has also been found in the pancreatic islets, where strong NOS immunoreactivity appeared in scattered cells which were peripheral in rat and mouse islets and more randomly distributed in human [11, 12] .
On the other hand, SS is a tetradecapeptide initially isolated from the hypothalamus as an inhibitor of pituitary growth hormone secretion [13] . SS acts as a negative regulator of pancreatic exocrine and endocrine secretions in both pancreas and gut. It has been previously reported that pancreatic acini possess speci¢c binding sites for SS, the binding of which results in the triggering of some biological actions of SS in the pancreas [14, 15] . In pancreatic acinar cells, SS receptors are negatively coupled to the adenylyl cyclase (AC) enzyme system via a guanine nucleotide-binding inhibitory protein (Gi-protein) [16] , leading to a decrease in adenosine 3P-5P cyclic monophosphate (cAMP) levels. Among its various inhibitory functions, SS decreases pancreatic amylase release [17] . An imbalance between NO and SS may contribute to alterations in pancreatic acinar cell secretion. The aim of this study was to determine whether NO regulates the SS receptor-effector system in rat pancreatic acinar membranes. In this regard, we evaluated the e¡ects of the NOS substrate L-Arg and the NOS inhibitor N g -L-arginine methyl ester (L-NAME) on the somatostatin receptors, SS-mediated inhibition of AC activity in rat pancreatic acinar membranes. Pancreatic somatostatin-like immunoreactivity (SSLI) content was also determined.
Materials and methods

Materials
The stable SS analogue SMS 201-995 and its tyrosine analogue Tyr 3 -SMS or SMS 204-090 were kindly donated by Sandoz (Basel, Switzerland). Collagenase (from Clostridium histolyticum) was obtained from Serva Fine Chemicals (Tebu, France). L-NAME, L-Arg, bacitracin, phenylmethylsulfonyl£uoride (PMSF), guanosine triphosphate (GTP), 3-isobutyl-1-methylxanthine (IBMX) and bovine serum albumin (BSA) were purchased from Sigma (St. Louis, MO, USA). Carrier-free Na[
125 I] (IMS 300, 100 mCi/ml) and the rabbit antibody used in the radioimmunoassay technique were purchased from the Radiochemical Center (Amersham, UK). This antiserum was raised in rabbits against SS-14 conjugated to BSA and is speci¢c for SS, but since SS-14 constitutes the C-terminal portion of both SS-25 and SS-28, the antiserum does not distinguish between these three forms. In the rat pancreas, SS-14 is the predominant molecular species, constituting 95% of total SS, whereas SS-28 seems to comprise less than 5% of the immunoreactivity [18] . All other agents were of the highest purity commercially available.
Experimental animals
The animal experiments performed in the present study were conducted under the guidelines of the Animal Care Committee of Alcalä University and the experimental protocols have been approved. Male Wistar rats weighing 200^250 g were injected intraperitoneally (i.p.) twice daily at 8 h intervals for 8 days with the following agents: L-NAME (50 mg/ kg) [19, 20] , L-Arg (150 mg/kg) [21^23], L-NAME plus L-Arg or saline in a volume (400 Wl) equal to that used for the other compounds. The animals were sacri¢ced 14 h after the last injection and the pancreas was removed and trimmed free of fat, connective tissues and lymph nodes.
Preparation of rat pancreatic acinar membranes
Dispersed pancreatic acini were obtained from male Wistar rats after enzymatic degradation of the organ with 0.2 units of collagenase/ml in an oxygenated Krebs-Ringer medium as described by Amsterdam et al. [24] . After thorough washing by sedimentation, acini were transferred to 0.3 M sucrose and homogenized at 4³C using of a Potter homogenizer following the method of Meldolesi et al. [25] . After sedimentation at 1500Ug for 12 min, the homogenized membranes were resuspended in 1.56 M sucrose. This suspension was overlaid with 0.3 M sucrose and centrifuged at 105 000Ug for 150 min. The plasma membrane-enriched fraction collected from the interphase was diluted with distilled water and centrifuged at 15 000Ug for 30 min. The supernatant was discarded and the pellet was resuspended in 50 mM Tris-HCl pH 7.4, 0.01 mg/ml bacitracin, 0.2 mM CaCl 2 and stored at 370³C. An aliquot was taken for protein determination by the method of Lowry et al. [26] . [29] membranes, was radioiodinated by the chloramine-T method and puri¢ed by HPLC according to Antoniotti et al. [30] . Its speci¢c radioactivity was found to be 900 Ci/ mmol.
Binding of [ 125 I-Tyr 3 ]SMS to pancreatic acinar membranes was carried out in a total volume of 250 Wl in 50 mM Tris-HCl bu¡er (pH 7.4) containing 0.5 mM MgCl 2 , 3 mM NaCl, 0.2 mM CaCl 2 , 0.2% (w/v) BSA, 0.5 mg/ml bacitracin and 0.3 mg/ml soybean trypsin inhibitor (binding bu¡er). Plasma membranes (36 Wg protein/ml) were incubated for 90 min at 20³C with 35 pM [ 125 I-Tyr 3 ]SMS in the absence or presence of 0.001^10 nM unlabeled SMS 201-995. Bound and free ligand were separated by centrifugation at 11 000Ug for 4 min at 4³C in a microcentrifuge. Radioactivity in the pellet was measured with a gamma scintillation counter. Non-speci¢c binding was estimated as membrane-associated radioactivity in the presence of 1 WM SMS and speci¢c binding was calculated as the di¡erence between total and non-speci¢c membrane-associated radioactivity.
Adenylate cyclase assay
Adenylate cyclase activity was measured as previously reported [31] with minor modi¢cations. Brie£y, rat pancreatic acinar membranes (0.12 mg protein/ ml) were incubated with 1.5 mM ATP, 5 mM MgSO 4 , 1 mM GTP and an ATP-regenerating system (7.5 mg/ml creatine phosphate and 1 mg/ml creatine kinase), 1 mM IBMX, 0.1 mM PMSF, 1 mg/ml bacitracin, 1 mM EDTA, and tested substances (10 39 M SMS 201-995 or 10 35 M forskolin (FK)) in 0.1 ml of 0.025 M triethanolamine-HCl bu¡er (pH 7.4). After a 30 min incubation at 30³C, the reaction was stopped by heating the mixture for 3 min. After cooling, 0.2 ml of an alumina slurry (0.75 g/ml in triethanolamine-HCl bu¡er, pH 7.4) was added and the suspension centrifuged. The supernatant was taken for assay of cyclic AMP by the method of Gilman [32] .
Tissue extraction and SS radioimmunoassay
[Tyr 11 ]SS was radioiodinated by chloramine-T iodination according to the method of Greenwood [33] . Separation of iodinated SS from unincorporated iodine was carried out on a Sephadex G-25 (¢ne) column equilibrated and eluted with 0.1 M acetic acid in BSA (0.1% w/v). Its speci¢c activity was found to be 900 Ci/mmol.
For SSLI measurement, the pancreas was rapidly homogenized in 1 ml of 2 M acetic acid using a Brinkman polytron (setting 5, 30 s). The extracts were boiled for 5 min, cooled in an ice-chilled water bath, and aliquots (100 Wl) were removed for protein determination [26] . The homogenates were subsequently centrifuged at 15 000Ug for 15 min at 4³C and the supernatant was neutralized with 2 M NaOH. The extracts were stored at 370³C until assay. The SS concentration was determined in tissue extracts by a modi¢ed radioimmunoassay method [34] , with a sensitivity limit of 10 pg/ml. Incubation tubes prepared in duplicate contained 100 Wl samples of tissue extracts or standard solutions of 0^500 pg of cyclic SS-14 diluted in phosphate bu¡er (0.05 M, pH 7.2 containing 0.3% BSA, 0.01 M EDTA), 200 Wl of appropriately diluted anti-SS serum and 100 Wl of freshly prepared [ 125 I-Tyr 11 ]SS diluted in bu¡er to give 6000 cpm (equivalent to 5^10 pg), in a ¢nal volume of 0.8 ml. All reagents as well as the assay tubes were kept chilled on ice before their incubation at 4³C for 48 h. Bound hormone was separated from free hormone by the addition of 1 ml of dextran-coated charcoal (dextran T-70, 0.2% w/v, Pharmacia, Uppsala, Sweden; charcoal: Norit A, 2% w/v, Serva, Feinbiochemica, Heidelberg, Germany). Serial dilution curves for the samples were parallel to the standard curve. The intra-and inter-assay variation coe¤cients were 6.0 and 8.8% respectively.
Data analysis
The LIGAND computer program [35] was used to analyze the binding data. The use of this program made it possible to select the models of receptors which best ¢t a given set of binding data. The same program was also used to present data in the form of Scatchard plots [36] and to compute the values for receptor a¤nity (K d ) and density (B max ) that best ¢t the sets of binding data for each rat. Statistical comparisons of all the data were analyzed by ANOVA and the Newman-Keuls t-test. Means among groups were considered signi¢cantly di¡erent when the P value was less than 0.05. Each individual experiment was performed in duplicate.
Results
Pancreatic somatostatin-like immunoreactivity content
The administration of L-Arg induced a signi¢cant decrease in SSLI content in the rat pancreas, whereas L-NAME or L-NAME plus L-Arg increased its content (Table 1) .
[I 125 -Tyr 3 ]SMS binding
Speci¢c [I 125 -Tyr 3 ]SMS binding to pancreatic acinar membranes changed linearly with protein concentration and was time-dependent in all experimental groups. An apparent equilibrium was observed between 60 and 120 min at 20³C (data not shown). All subsequent binding experiments were therefore conducted at 20³C for 90 min.
Speci¢c [ 125 I-Tyr 3 ]SMS binding to rat pancreatic acinar cell membranes was signi¢cantly decreased in L-Arg-treated rats as compared to control rats (Fig. 1, left panel, Table 2 ). This decrease was due to a decrease in the maximal number of SS receptors with no changes in the dissociation constant, as revealed by Scatchard plots of the binding data (Fig. 1, right panel, Table 2 ). The administration of L-NAME+L-Arg reverted the number of SS receptors to control values whereas L-NAME alone increased the SS receptor density. The addition of 10 34^1 0
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M of L-Arg and/or L-NAME to the incubation medium changed neither the number nor the a¤nity of the SS receptors in pancreatic acinar cell membranes from normal rats (data not shown). 
Adenylyl cyclase assay
The functional coupling of the SS receptors to the AC system was also investigated. To study the SMSmodulated AC activity, pancreatic acinar cell membranes were incubated with SMS (10 39 M) either alone or together with FK (10 35 M), a direct AC activator. As shown in Table 3 , no signi¢cant di¡er-ences were seen for either basal or FK-stimulated AC enzyme activity in pancreatic acinar cell membranes from control, L-Arg-and/or L-NAME-treated rats. The e¡ect of SMS 201-995 on FK-stimulated AC activity was markedly decreased in pancreatic acinar membranes from L-Arg-treated rats as compared to control animals (Table 3 ). This e¡ect, however, was increased in pancreatic acinar membranes from L-NAME-treated rats, whereas the administration of L-NAME+L-Arg reverted this e¡ect to control values.
Discussion
The present study shows that L-Arg, a substrate for NO production, decreases pancreatic SSLI levels and the number of speci¢c SS receptors, without altering their a¤nity, in rat pancreatic acinar cell membranes. In addition, L-Arg induces a decrease in the inhibitory e¡ect of SMS 201-995 on AC activity in these membranes.
The L-Arg concentration used in the present study was in agreement with the dose reported by others and has been demonstrated to induce NO production [21^23] . The choice of L-NAME was dictated by its previous characterization as a NOS inhibitor [37^39]. In addition, Bannerman et al. [20] and Dwyer et al. [19] have shown that the level of NOS inhibition actually increases with repeated injections.
The pancreatic SSLI levels in the control rats were similar to those previously reported by others [14, 40] . L-Arg has been described to produce a dose-related increase of SS release from the isolated perfused rat pancreas [41] . On the other hand, the intracellular concentration of Ca 2 , which is known to be a potent stimulator of SS secretion [42, 43] , is increased by NO. Therefore, it is possible that the increase of SS release by the D-cells of the islets of Langerhans could lead to a decrease of pancreatic SSLI levels found in L-Arg-treated rats.
Although ¢ve SS receptors subtypes have thus far been cloned [44] , the rat exocrine pancreas appears to express only SS receptor subtype 2 (sst2) [45] . Therefore, the present results suggest that the changes in the SS receptor number observed after L-Arg or Table 3 The e¡ect of SMS 201-995 (10 39 M) and FK (10 35 M) on AC activity (pmol cAMP/min/mg protein) in pancreatic acinar membranes from rats treated for 8 days with saline, L-Arg, L-NAME or L-NAME plus L-Arg Table 2 .
L-NAME administration could result, at least in part, from changes of the sst2 subtype. The binding parameters of the SS receptors in the control rats were similar to those previously reported by others [14, 15] .
The changes in [ 125 I-Tyr 3 ]SMS binding were not a result of a direct e¡ect of L-Arg or L-NAME on the SS receptors, since no change in tracer binding was detected following incubation of fresh pancreatic acinar cell membranes with L-Arg or L-NAME. In addition, NO seems to mediate the action of L-Arg on the SS receptor-e¡ector system because the changes in SS binding and the inhibitory e¡ect of this neuropeptide on AC activity induced by L-Arg were prevented by pretreatment with the NOS inhibitor L-NAME which, when administered alone, increased both parameters.
At present, we can only speculate on the identity of the postreceptor mechanisms responsible for the regulation of the SS receptors by NO in rat pancreatic acinar cell membranes. Although most of the NO actions have been reported to be mediated by elevation of cGMP synthesis through activation of soluble guanylate cyclase [1] , cGMP has been shown to have no e¡ect on SS binding [46] . Recently, NO has been shown to be involved in Ca 2 transport in pancreatic acinar cells [42, 43] . Willmott et al. [43] suggest an action of NO in mobilizing intracellular Ca 2 from microsomal stores via a signaling pathway involving cGMP and cyclic adenosine diphosphate ribose (cADP). As reported previously, the activation of Ca 2 -activated phospholipid-dependent protein kinase C (PKC) and intracellular Ca 2 mobilization can inhibit the binding of SS to its receptors [47] . Therefore, it is possible that the increase of intracellular Ca 2 induced by endogenous NO could decrease the number of SS receptors in pancreatic acinar cell membranes.
On the other hand, pancreatic acinar cells, which do not synthesize SS but possess functional SS receptors [48] , may respond to SS produced in the pancreas by the D-cells in the islets of Langerhans as well as to circulating SS. Therefore, it is possible that an increased pancreatic SS release induced by L-Arg could cause a decrease in the number of SS receptors in pancreatic acinar cell membranes.
SMS 201-995 did not modify basal AC activity and was a partial antagonist of FK-stimulated pancreatic AC activity in agreement with other authors [49] . The ability of SMS 201-995 to inhibit FKstimulated AC was decreased in pancreatic acinar membranes from L-Arg-treated animals when compared with controls. However, this does not appear to be due to any defect in the catalytic subunit of AC itself. Indeed, similar levels of activities were noted in membranes from both control and L-Arg-treated animals when the enzyme was stimulated directly by the diterpene FK. In this regard, it has been recently reported that NO and L-NAME do not modify basal cAMP levels nor that stimulated by human chorionic gonadotrophin hormone (hCG) in the MA-10 murine Leydig tumor cell line [50] and mouse brain [51] , respectively.
The physiological signi¢cance of the L-Arg-induced down-regulation of the SS receptor-e¡ector system is presently unknown. NO has been demonstrated to increase amylase release [5] , whereas SS has been shown to decrease it [52] . In the present study we have demonstrated that L-Arg, the substrate of NOS, induces a decrease in the number of SS receptors and in SMS-mediated inhibition of AC activity. Therefore, it is possible the increase of amylase secretion induced by NO might be due to this L-Arg-induced decrease of the somatostatinergic system. Moreover, these results suggest that the reduced ability of SMS to inhibit AC activity is most probably due to the decrease in the number of SS receptors alone.
On the other hand, we have shown that L-Arg reduces SSLI content in the pancreas. It is well established that SS inhibits insulin secretion [53] . NO, however, has a stimulatory e¡ect on insulin secretion [8^10]. Since L-Arg is the substrate for NO production, it is tempting to speculate that the decrease of SSLI caused by L-Arg is responsible for the NOmediated increase of insulin release.
Altogether, these results indicate that the NO system may contribute to the regulation of the pancreatic somatostatinergic system.
